This company is no longer active
Angion Biomedica Balance Sheet Health
Financial Health criteria checks 4/6
Angion Biomedica has a total shareholder equity of $39.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $41.8M and $2.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$29.22m |
| Equity | US$39.67m |
| Total liabilities | US$2.10m |
| Total assets | US$41.77m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5YX's short term assets ($40.6M) exceed its short term liabilities ($2.0M).
Long Term Liabilities: 5YX's short term assets ($40.6M) exceed its long term liabilities ($70.0K).
Debt to Equity History and Analysis
Debt Level: 5YX is debt free.
Reducing Debt: 5YX has no debt compared to 5 years ago when its debt to equity ratio was 5.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5YX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 5YX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.7% each year